UCLA (glial malignancies only) — Los Angeles, California

UCLA (glial malignancies only) is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

UCLA (glial malignancies only) has participated in 1 clinical trials.

Therapeutic areas: Gastrointestinal Stromal Tumors, Advanced Systemic Mastocytosis, Advanced Cancers.

Sponsors: Deciphera Pharmaceuticals, LLC.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA (glial malignancies only)?

UCLA (glial malignancies only) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA (glial malignancies only) conducted?

UCLA (glial malignancies only) has 1 clinical trials on record. Their work covers Gastrointestinal Stromal Tumors, Advanced Systemic Mastocytosis, Advanced Cancers.

Is UCLA (glial malignancies only) accredited by Crixeo Health?

UCLA (glial malignancies only) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA (glial malignancies only)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.